- Home
- HROW
HROW
Harrow Inc.
as 07-26-2024 4:00pm EST
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans.
| Founded: | 1998 | Country: | United States |
| Employees: | N/A | City: | NASHVILLE |
| Market Cap: | 609.3M | IPO Year: | N/A |
| Target Price: | $28.00 | AVG Volume (30 days): | 352.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.92 | EPS Growth: | N/A |
| 52 Week Low/High: | $7.60 - $25.58 | Next Earning Date: | 08-07-2024 |
| Revenue: | $138,677,000 | Revenue Growth: | 49.79% |
| Revenue Growth (this year): | 44.73% | Revenue Growth (next year): | 40.12% |
Latest Harrow Inc. News
HROW Breaking Stock News: Dive into HROW Ticker-Specific Updates for Smart Investing
Business Wire
2 days ago
Harrow To Report Second Quarter 2024 Financial Results After Market Close on August 7, 2024
Business Wire
15 days ago
Harrow to Attend 2024 ASRS Annual Meeting
Business Wire
18 days ago
Harrow Enters into 340B Prime Vendor Program Contract with Apexus™ for IHEEZO® and Other Key Harrow Products
Business Wire
a month ago
Harrow Provides TRIESENCE® Relaunch Update
Business Wire
2 months ago
Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition
GlobeNewswire
2 months ago
Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus
GlobeNewswire
2 months ago
Share buy-back programme - week 23
Simply Wall St.
2 months ago
Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?
Compare HROW vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HROW Harrow Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.